CDE Catalog

***Please contact the NINDS CDE Team (NINDSCDE@emmes.com) if you encounter any search difficulties.***

The CDE Catalog is a directory of the available NINDS CDEs. Users can search the Catalog to isolate a subset of the CDEs (e.g., all stroke-specific CDEs, etc.), and to view and download details about the CDEs.

Select any filter below to search the CDE Catalog.

For best results, clear form between searches. In addition, when specifying NeuroRehab, Sport-Related Concussion (SRC) or Traumatic Brain Injury (TBI) as the Disease, please select a Subdisease as well.

NeuroRehab Comprehensive includes all NeuroRehab CDE recommendations. NeuroRehab General includes all NeuroRehab CDE recommendations that are not disease specific. All other NeuroRehab Subdiseases include recommendations specific to existing NINDS CDE project disorders.

Choose your Time Frame for your SRC study (Acute (time of injury until 72 hours), Subacute (after 72 hours to 3 months), and Persistent/Chronic (3 months and greater post-concussion) or Comprehensive if your study falls across the study time frames.

Choose your type of TBI study (Acute Hospitalized, Concussion/Mild TBI, Moderate/Severe TBI: Rehabilitation, or Epidemiology) or Comprehensive if your study falls outside of the study types or incorporates aspects of more than one type of study.

Search Form

Displaying 651 - 675 of 1834
Operations
Selected 25 rows in this page.  
The search results below can be downloaded by clicking the checkboxes on the far left side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
CDE ID CDE Name Definition Classification CRF Name Copyrighted or trademarked Disease Name Subdisease Name
C20221 Mitochondrial disease alternative medicine type other text

The free text field related to 'Mitochondrial disease alternative medicine type' specifying other text. Type of alternative medications that the participant has tried

Supplemental Mitochondrial and Gastrointestinal Diseases Assessment Mitochondrial Disease Mitochondrial Disease
C20220 Mitochondrial disease alternative medicine type

Type of alternative medicine tried by the participant

Supplemental Mitochondrial and Gastrointestinal Diseases Assessment Mitochondrial Disease Mitochondrial Disease
C20223 Mitochondrial disease alternative medicine treatment gastrointestinal problem worsen text

The free-text field to specify about which alternative medicine treatments made the participant's GI problems worse

Supplemental Mitochondrial and Gastrointestinal Diseases Assessment Mitochondrial Disease Mitochondrial Disease
C20222 Mitochondrial disease alternative medicine treatment gastrointestinal problem improve text

The free-text field to specify about which alternative medicine treatments made the participant's GI problems better

Supplemental Mitochondrial and Gastrointestinal Diseases Assessment Mitochondrial Disease Mitochondrial Disease
C20219 Mitochondrial disease alternative medicine treat GI problem indicator

Indicator of whether the participant has tried to treat GI problems with alternative medicine

Supplemental Mitochondrial and Gastrointestinal Diseases Assessment Mitochondrial Disease Mitochondrial Disease
C60328 Mitochondrial disease acute pancreatitis indicator

Indicator of whether the participant had acute pancreatitis

Supplemental Mitochondrial and Gastrointestinal Diseases Assessment Mitochondrial Disease Mitochondrial Disease
C20155 Mitochondrial disease abdominal pain current prior status

Status of whether the participant's abdominal pain is current or prior

Supplemental Mitochondrial and Gastrointestinal Diseases Assessment Mitochondrial Disease Mitochondrial Disease
C60281 Mitochondrial disease abdominal migraine diagnosis indicator

Indicator of whether the participant has an abdominal migraine diagnosis

Supplemental Mitochondrial and Gastrointestinal Diseases Assessment Mitochondrial Disease Mitochondrial Disease
C20187 Mitochondrial disease abdominal early fullness indicator

Indicator of whether the participant experiences early fullness

Supplemental Mitochondrial and Gastrointestinal Diseases Assessment Mitochondrial Disease Mitochondrial Disease
C60237 Metabolomic type

Type of metabolic testing performed

Supplemental Biomarkers in Mitochondrial Disease Mitochondrial Disease Mitochondrial Disease
C16170 Menstrual period occurrence indicator

Indicates whether participant has ever had a menstrual period

Supplemental Reproductive and Hormonal History Mitochondrial Disease Mitochondrial Disease
C16175 Menstrual period last date

Date of the participant's last menstrual period

Supplemental Reproductive and Hormonal History Mitochondrial Disease Mitochondrial Disease
C16171 Menstrual period first occurrence age value

Youngest age the participant had a menstrual period, otherwise known as the age of menarche

Supplemental Reproductive and Hormonal History Mitochondrial Disease Mitochondrial Disease
C16174 Menopause indicator

Indicates whether participant is currently menopausal

Supplemental Reproductive and Hormonal History Mitochondrial Disease Mitochondrial Disease
C59724 Medication testosterone HCG current indicator

Indicator of whether the participant is currently taking any testosterone (injection, patch, gel, other) or HCG (injection)

Supplemental Bone Health History Mitochondrial Disease Mitochondrial Disease
C59728 Medication teriparatide indicator

Indicator of whether the participant is or has ever taken teriparatide (Forteo)

Supplemental Bone Health History Mitochondrial Disease Mitochondrial Disease
C59725 Medication stop puberty current indicator

Indicator of whether the participant is currently taking any medications to stop puberty

Supplemental Bone Health History Mitochondrial Disease Mitochondrial Disease
C59716 Medication steroid mouth current indicator

Indicator of whether the participant is taking any oral steroids by mouth

Supplemental Bone Health History Mitochondrial Disease Mitochondrial Disease
C59718 Medication steroid IV current indicator

Indicator of whether the participant is taking any steroids by IV

Supplemental Bone Health History Mitochondrial Disease Mitochondrial Disease
C59717 Medication steroid inhaler current indicator

Indicator of whether the participant is taking any steroids by inhaler

Supplemental Bone Health History Mitochondrial Disease Mitochondrial Disease
C59719 Medication seizure current indicator

Indicator of whether the participant is taking any seizure medications

Supplemental Bone Health History Mitochondrial Disease Mitochondrial Disease
C59730 Medication romusuzumab indicator

Indicator of whether the participant is or has ever taken romusuzumab (Evenity)

Supplemental Bone Health History Mitochondrial Disease Mitochondrial Disease
C20258 Medication reduce blood sugar prior diagnosis type

The type of the medication to reduce blood sugar levels taken by the participant prior to diagnosis of the condition/disorder

Exploratory Diabetes-Related Medical History Mitochondrial Disease Mitochondrial Disease
C20257 Medication reduce blood sugar prior diagnosis diabetes indicator

The indicator of whether the participant had been on medication to reduce blood sugar levels prior to diagnosis of the diabetes

Exploratory Diabetes-Related Medical History Mitochondrial Disease Mitochondrial Disease
C59723 Medication other progesterone current indicator

Indicator of whether the participant is currently taking other progesterone forms (pill, implant, intra-uterine device, other)

Supplemental Bone Health History Mitochondrial Disease Mitochondrial Disease
Displaying 651 - 675 of 1834

The NINDS CDE Team does not post proprietary instruments/scales recommended by the CDE Working Groups on this website. This includes, but is not limited to, copyrighted or trademarked instruments/scales. Information about recommended instruments can be found in the Notice of Copyright (NOC) documents under ‘CRF Module/Guideline’ on each disorder’s data standards page. For any questions regarding these instruments/scales please contact the corresponding owner/author. The NINDS CDE Team is not responsible for the availability or content of these external sites, nor does the NINDS CDE Team endorse, warrant or guarantee the products, services or information described or offered at these other internet sites.